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INTRODUCTION
Approximately 779 million people are at great risk (85% in 
Africa) in 78 countries of which 42 are in Africa, and 207 mil-
lion (97% in sub-Saharan Africa) are estimated to be affected 
by schistosomiasis [1]. Out of estimated 201.5 million people 
infected in sub-Saharan Africa (both Schistosoma mansoni and 
Schistosoma haematobium) [1], more than a half experience 
substantial morbidity [2]. It was estimated that about 54 mil-
lions are infected with S. mansoni in sub-Saharan Africa, and 
about 0.93 millions are with hematemesis, likely having severe 
hepatosplenic morbidity due to intestinal schistosomiasis [2]. 
This corresponds with the annual incidence of 180,000 with 
hematemesis, of whom 83.3% die annually and also with liver 
failure being responsible for extra-substantial proportion of 
death.
Morbidity in intestinal schistosomiasis related to S. mansoni 
involves the intestinal tract, manifesting with diarrhea, ab-
dominal pain, and blood in the stools. Also infection with S. 
mansoni may present as hepatosplenic schistosomiasis, charac-
terized by enlargement of the liver and spleen and accompa-
nied by increased firmness of the organs [3]. Many of the eggs 
(about a half) excreted by S. mansoni enter the systemic circu-
lation via the portal vein and lodge in the liver [4], where they 
give rise to vascular and inflammatory granulomatous changes 
that can lead to periportal fibrosis, portal hypertension with 
development of esophageal varices, and the risk of life-threat-
ening hematemesis.
Tanzania is among the 7 countries (Burkina Faso, Mali, Sier-
ra Leon, Ghana, Mozambique, Tanzania, and Madagascar) 
ISSN (Print) 0023-4001
ISSN (Online) 1738-0006
Korean J Parasitol Vol. 53, No. 5: 545-551, October 2015 
http://dx.doi.org/10.3347/kjp.2015.53.5.545▣ORIGINAL ARTICLE 
•Received 23 July 2015, revised 30 September 2015, accepted 30 September 2015.
*Corresponding author (tsyong212@yuhs.ac)
© 2015, Korean Society for Parasitology and Tropical Medicine
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Schistosoma mansoni-Related Hepatosplenic Morbidity in 
Adult Population on Kome Island, Sengerema District, 
Tanzania
Godfrey M. Kaatano1, Duk-Young Min2, Julius E. Siza1, Tai-Soon Yong3,*, Jong-Yil Chai4, Yunsuk Ko5,  
Su-Young Chang5, John M. Changalucha1 , Keeseon S. Eom6, Han-Jong Rim7 
1National Institute for Medical Research, P.O. Box 1462, Mwanza, Tanzania; 2Department of Immunology and Microbiology, Eulji University School of 
Medicine, Daejeon 34824, Korea; 3Department of Environmental Medical Biology, Institute of Tropical Medicine and Arthropods of Medical 
Importance Resource Bank, Yonsei University College of Medicine, Seoul 03722, Korea; 4Department of Parasitology and Tropical Medicine, Seoul 
National University College of Medicine, Seoul 03080, Korea; 5Good Neighbors International, Tanzania Western Chapter, P.O. Box 367, Mwanza, 
Tanzania; 6Department of Parasitology, Medical Research Institute and Parasite Resource Bank, Chungbuk National University School of Medicine, 
Cheongju 28644, Korea; 7Department of Parasitology, College of Medicine, Korea University, Seoul 02841, Korea
Abstract: Schistosomiasis is one of the important neglected tropical diseases (NTDs) in Tanzania, particularly in Lake Vic-
toria zone. This baseline survey was a part of the main study of integrated control of schistosomiasis and soil-transmitted 
helminths (STHs) aimed at describing morbidity patterns due to intestinal schistosomiasis among adults living on Kome 
Island, Sengerema District, Tanzania. Total 388 adults from Kome Islands (about 50 people from each village) aged be-
tween 12 and 85 years, were examined by abdominal ultrasound according to the Niamey protocol. Liver image patterns 
(LIPs) A and B were considered normal, and C-F as distinct periportal fibrosis (PPF). The overall prevalence of PPF was 
42.2%; much higher in males than in females (47.0% in male vs 34.4% in females, P=0.007). Abnormal increase of seg-
mental branch wall thickness (SBWT) and dilated portal vein diameter (PVD) were also more common in males than in fe-
males. Hepatosplenomegaly was frequently encountered; 68.1% had left liver lobe hepatomegaly and 55.2% had sple-
nomegaly. Schistosoma mansoni-related morbidity is quite high among adults in this community justifying the implemen-
tation of integrated control strategies through mass drug administration, improved water supply (pumped wells), and 
health education that had already started in the study area.
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most severely affected with schistosomiasis, classified as high 
prevalence setting [5]. Intestinal schistosomiasis, due to S. 
mansoni, is a serious public health problem which is endemic 
in many parts of Tanzania [6]. About 19% of the population 
in Tanzania is constantly exposed to S. mansoni infection espe-
cially in rural and peri-urban areas [7]. In Tanzania, extensive 
transmission of S. mansoni occurs along the shores of the Great 
Lakes [6] and areas of Lake Victoria basin including the lake 
shores and its associated islands are the most affected areas in 
Tanzania. For instance among adults from randomly selected 
villages in Ukerewe islands, Kardoff et al. [8] and Malengan-
isho et al. [9] found a prevalence of 86% in Galu and Muriti 
villages and 78% in Musozi village, respectively. Of those ex-
amined adults, about 41.5% in Musozi village and 30.0% in 
Miriti and Galu villages had periportal fibrosis [8,9]. There is 
also evidence that the level of S. mansoni transmission is in-
creasing also in the northeastern and western parts of Lake 
Victoria shore that previously was regarded as low level or free 
of transmission areas [10].
  Although it is quite clear that, in S. mansoni endemic areas, 
children and young adolescents exhibit the highest prevalence 
and intensity of infection [11]; however, severe late-stage con-
sequences are likely during the adulthood, despite generally 
lower intensities of infection. In order to determine the S. 
mansoni-related hepatosplenic morbidity, the present study 
targeted on the adult community for collecting morbidity 
baseline data as mass drug administration (MDA) and other 
interventions in this control programme targeting all commu-
nity members of 4 year and above. 
MATERIALS AND METHODS
Study area and population
Kome Island is a 5th largest island (after Ukerewe, Rubon-
do, Ukara, and Mwaisome) out of 48% portion of Lake Victo-
ria surface controlled by Tanzania. The island is in Sengerema 
District and is situated at longitudinal 32024” and 32024 east 
and latitude 2014’ and 2025. According to the 2002 National 
census, Kome Island had a population of 38,062 with an aver-
age growth rate of 2.9%. Administratively, it has 2 wards, 9 vil-
lages and 53 sub-villages. It is served by 1 health centre and 2 
dispensaries. It has 10 primary schools and 2 secondary 
schools in each ward, with almost each village having a prima-
ry school, with an exception of Lugata village which has 3 pri-
mary schools.
The sources of water for drinking, washing, and other chores 
are Lake Victoria, natural wells, and streams. The lake harbours 
the snail intermediate hosts for schistosomes mainly Biomphal-
aria choanomphala and Biomphalaria sudanica [6,12]. Occupa-
tionally most of the people are engaged in peasant farming 
and fishing activities. They grow cassava, maize, and sweet po-
tatoes as food crops and cotton as a cash crop. Livestock in-
clude cattle, goats, chickens, ducks, and a few pigs. All the oc-
cupational as well as recreational activities have obvious bear-
ing to acquisition and transmission of intestinal schistosomia-
sis, soil-transmitted helminths (STHs), and other parasitic dis-
eases like malaria and amebiasis in the study area. 
Study design and sampling procedure
A cross sectional study was conducted on Kome Island in 
February 2009 to obtain baseline data on S. mansoni infection 
status and S. mansoni-related hepatosplenic morbidity using 
ultrasonography before implementation of intervention. Be-
fore the survey, meetings were held in each village and the 
purpose of the study was explained. About 50 adult partici-
pants in each 8 villages (all villages in Kome Island) were ran-
domly selected and recruited to participate in this study. A sub-
sample of older (12 years and above) schoolchildren (13 in 
Lugata Secondary School and 20 in Kabaganga Primary 
School) were also recruited.
Data collection, materials and methods 
 Participants were given a container to collect stool speci-
mens. The cllected stools were processed by the Kato-Katz 
technique using a 42.7 mg template, and microscopic exami-
nation of the prepared Kato’s slides for S. mansoni eggs was 
carried out in the field. The mean intensity of S. mansoni eggs 
was determined by taking the average number of eggs in each 
slide and then multiplying by 24 to obtain the number of eggs 
per gram (epg) of feces, which is referred as the intensity of in-
fection. 
Ultrasound examination was performed using a portable ul-
trasound, according to standard guidelines proposed by Nia-
mey working group [13]. A portable ultrasound scanner 
equipped with a 3.5 MHz curved array transducer was used. 
The size of the liver (left and right lobes) and spleen was mea-
sured and their height adjusted according to the reference 
population. The portal hypertension (PH) score was calculated 
by combining the measurement of the diameter of the lumen 
of the portal vein (PV) and screening for the presence of ascites 
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(ascites score) and porto-systemic collateral vessels (collateral 
score). For comparison of age independent analysis of organo-
metric data, we used established height-related reference data 
of Senegalese African community for the values of liver, spleen, 
and main portal vein [14]. 
Both methods, qualitative using pattern image and quanti-
tative by measuring segmental branch wall thickening (PBWT), 
were used in assessing periportal fibrosis. The liver image pat-
tern (LIP) was assessed as pattern A, B, C, D, E, and F accord-
ing to the guidelines [13]. Periportal thickening seen by ultra-
sonography as echo dense areas was measured at the level of 
the first segmental branches leaving the left branches of the 
main portal vein at the point where the most substantial wall 
thickness was observed. Segmental branch wall thickness 
(SBWT) was obtained by measuring external (outer to outer) 
diameter followed by measurement of lumen (inner to inner) 
diameter. The difference between the 2 measurements was re-
corded as PBWT. The gall bladder wall thickness was measured 
when the gall bladder was well visualized. The thickness of the 
gall bladder was categorized as normal when it was less than 4 
mm, or increased when greater or equal to 4 mm in diameter.
Data handling and analysis
Ultrasonographic organomegaly was defined as the left liver 
lobe, right liver lobe, or spleen length exceeding 2SD above 
the normal reference value, whereas right liver lobe shrinkage 
was defined as exceeding negative 2SD below normal refer-
ence value. The main portal vein and PBWT dilatation were 
also considered present if exceeding 2SD above the normal 
reference value. Patterns A and B were considered to show no 
PPF while C, D, E, and F were recorded as PPF. The cases with 
pattern B and PBWT exceeding 2SD were considered as PPF.   
Data entry was done using Dbase IV (Borland International, 
Scotts Valley, California, USA) and a double entry system was 
used for quality control. Data was transferred to STATA version 
8 software (Stata Corp 2000, College Station, Texas, USA) for 
analysis. Analysis was done by generation of some frequency 
tables, cross tabulations, and calculation of the prevalence. To 
compare the mean intensity of infection by sex, age groups, 
and village, t-test was used. Means were regarded as significant 
if t<0.05. For comparing PPF and infection prevalence (pro-
portion) by respective groups as above, the chi-square test was 
used and a proportion was considered as significant if P<0.05.
RESULTS
A total of 388 participants were recruited for ultrasonogra-
phy and parasitological examinations. Due to a logistical 
Table 1. Prevalence of periportal fibrosis (PPF) and segmental branch wall thickening (PBWT), portal pressure, and S. mansoni  infection 






S. mansoni infection status
Prevalence Intensity of infection
Total Male Female No. exam. Total Male Female All Male Female
10-19 29 11 (37.9) 7 (46.7) 4 (28.6) 30 19 (63.3) 11 (65.8) 8 (57.1) 65.7 11   (65.8) 8   (57.1)
20-29 67 28 (41.8) 17 (51.5) 11 (32.4) 70 27(38.6) 17 (50.0) 10 (27.9) 88.0 17   (50.0) 10   (27.9)
30-39 96 47 (49.0) 31 (56.4) 16 (39.0) 107 8 (26.2) 16 (28.1) 12 (24.0) 97.7 16   (28.1) 12   (24.0)
40-49 79 31 (39.2) 21 (45.7) 10 (30.0) 83 24 (28.9) 14 (29.8) 10 (27.8) 118.0 14   (29.8) 10   (27.8)
50-60 52 24 (46.2) 15 (48.4) 9 (42.9) 56 14 (25.0) 10 (30.3) 4 (17.4) 156.0 10   (30.3) 4   (17.4)
60 and over 37 11 (29.7) 6 (30.0) 5 (29.4) 42 9 (21.4) 7 (29.2) 2 (11.2) 128.0 7   (29.2) 2   (11.2)
Total 360 152 (42.2) 97 (48.5) 55 (34.4) 388 121 (31.2) 75 (35.5) 46 (26.0) 75   (35.5) 46   (26.0)
Village name
Nyamiswi 28 13 (46.4) 8 (47.1) 5 (45.5) 37 4 (10.8) 2 (10.5) 2 (11.1) 42.0 2   (48) 2   (36)
Bugoro 45 22 (48.9) 15 (50.0) 7 (46.7) 50 7 (14.0) 7 (21.2) 0   (0.0) 76.4 7   (75.4) 0     (0.0)
Lugata 56 19 (33.9) 13 (36.1) 6 (30.0) 58 14 (24.1) 10 (27.0) 4 (19.1) 56.6 10   (62.4) 4   (42)
Buhama 40 12 (30.0) 6 (30.0) 6 (30.0) 46 13 (28.3) 6 (30.0) 7 (26.9) 112.6 6 (104) 7 (120)
Kabaganga 54 21 (38.9) 11 (42.3) 10 (35.7) 57 22 (38.6) 12 (41.4) 10 (35.7) 63.3 12   (78) 10   (45.6)
Isenyi 39 22 (56.4) 17 (77.3) 5 (29.4) 40 14 (35.0) 9 (39.1) 5 (29.4) 97.7 9 (109.3) 5   (76.8)
Nyakasasa 48 19 (39.6) 16 (57.1) 3 (15.0) 50 21 (42.0) 14 (48.3) 7 (33.3) 126.8 14 (102.8) 7   (74.8)
Izindabo 50 24 (48.0) 11 (52.4) 13 (44.8) 50 26 (52.0) 15 (71.3) 11 (37.9) 159.7 13 (216) 11   (82.9)
Total 360 152 (42.2) 97 (48.5) 55 (34.4) 388 121 (31.2) 75 (35.6) 46 ( 26.0)
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problem, 32 individuals in Buhama village were not measured 
for the left liver lobe size, right liver lobe size, and main portal 
vein size, including 5 individuals in Kabaganga village in 
whom their heights were not taken. These cases were therefore 
excluded from the analysis of organometric data. Of 388 in-
cluded, 28 (7.2%) individuals had other abnormalities and 
hence were excluded in scoring and assessing PPF using the 
pattern image. 
Of the 360 total individuals examined by ultrasonography, 
152 (42.2%) had evidence of periportal fibrosis (PPF) (by 
LIP); 30.6% had mild PPF (pattern B, C, and D) and 10.8% 
had severe PPF (pattern E and F). Of 36 with severe PPF, 29 
(8.8%) had pattern E and 7 (2.0%) had pattern F. Of 152 with 
PPF, 87.2% (136/152) of them had evidence of SBWT; thus 
being confirmed by quantitative method of assessing PPF. The 
prevalence of PPF was higher in male (47.0%) than in female 
(34.4%; P=0.007). The prevalence of severe PPF was also re-
markably higher in male (15%) than in female (5%; P =  
0.001). The prevalence of PPF increases with age and then al-
most remained constant throughout the adulthood. The prev-
alence of PPF was consistently high in all 8 villages; Isenyi vil-
lage leading with 56.4% prevalence while Buhama village was 
the lowest with 30.0%. The prevalence of S. mansoni was also 
higher in male (35.6%) than in female (26.0%; P=0.043) but 
the prevalence decreased with increase in age (Table 1). 
Fecal egg excretion in positive cases was between 24 and 
984 (median 48). There was no difference of median or mean 
egg excretion by sex (median, male 48 epg vs female 48 epg; 
mean, male 113.0 epg vs female 88.2 epg, P=0.3708). The 
quantitative fecal egg excretion (mean epg) was the highest in 
the older age group (156.0 and 128.0 epg in the 50-59 and 60 
and over age groups, respectively), and in Izindabo (159.7 
epg) and Nyakasasa (126.8 epg) villages. However, the differ-
ences from the rest age groups and villages were not significant 
by Pearson chi-square or t-test. 
  Hepatosplenomegaly assessed as non-specific findings re-
lated to S. mansoni infection was also common in Kome Is-
land; 55.2% had splenomegaly and 68.1% had left lobe hepa-
tomegaly. The prevalence of the right liver lobe shrinkage was 
14.8%, and the right liver lobe enlargement was 6.7%. The 
shrinkage of the right liver lobe was higher in male (19.0%) 
than in female (9.6%; P=0.014) (Table 2).
Of 152 patients with PPF, 24 (15.8%) had irregular or nod-
ular liver surface, 10 (5.9%) showed that their liver edge was 
abnormally round, and 27 (17.1%) showed distorted or con-
vexed liver shape. The gall bladder wall thickness as an evi-
dence of involvement by periportal fibrosis was present in 67 
patients (44.1%). In all of these 67 cases, gallbladder wall 
thickening was associated with central portal fibrosis. Collater-
al vessels were detected in 42 patients (27.6%) and ascites in 4 
patients (2.6%).
Twenty-eight had other specified pathological abnormalities 
of the liver not to be related to S. mansoni infection; their ma-
jority had fatty liver (24.4%), hemangioma (17.9%), and gall-
stone (10.7%).
Table 2. Prevalence of organomegaly and portal pressure by sex and village name in Kome Island, Sengerema, Tanzania   
Category





No. exam. Spleen No. exam. PHT
Enlarged Shrinked
Sex
Male 195 128 (65.6) 10   (5.1) 37 (19.0) 208 112 (53.9) 200 72 (36.0)
Female 156 111 (71.2) 14   (9.0) 15   (9.6) 174 99 (56.9) 160 52 (32.5)
Total 351 239 (68.1) 24   (6.7) 52 (14.8) 382 211 (55.2) 360 124 (34.4)
Village name
Nyamiswi 37 18 (48.7) 3   (8.1) 4 (10.8) 37 17 (45.9) 28 4 (14.3) 
Bugoro 50 43 (86.0) 2   (4.0) 8 (16.0) 50 26 (52.0) 45 16 (35.6)
Lugata 58 37 (63.8) 5   (8.6) 10 (17.2) 58 28 (48.3) 56 11 (19.6)
Buhama 14 7 (50.0) 0   (0.0) 3 (21.4) 45 26 (57.8) 40 34 (85.0) 
Kabaganga 52 33 (63.5) 3   (5.8) 4   (7.7) 52 31 (59.6) 54 14 (25.9)
Isenyi 40 28 (70.0) 3   (7.5) 6 (15.0) 40 31 (77.5) 39 17 (34.6)
Nyakasasa 50 37 (74.0) 5 (10.0) 9 (18.0) 50 28 (56.0) 48 12 (25.0)
Izindabo 50 36 (72.0) 3   (6.0) 8 (16.0) 50 24 (48.0) 50 16 (32.0)
Total 351 239 (68.1) 24   (6.8) 52 (14.8) 382 211 (55.2) 360 124 (34.4) 
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DISCUSSION 
The baseline finding clearly shows that there is high preva-
lence of PPF (42.2%) and other S. mansoni-related hepato-
splenic morbidity in the communities of Kome Island. The left 
lobe hepatomegaly that was found in 68.1%, the right liver 
lobe shrinkage in 14.8%, and splenomegaly in 55.2% indicat-
ed a high morbidity in Kome community caused by S. mansoni 
infection. The prevalence of PPF in this community was simi-
lar to 41.5% observed by Malenganisho et al. [9] in Musozi 
village which is believed to be most highly affected with intes-
tinal schistosomiasis in Ukerewe District. However, our figure 
was comparatively higher than 30.0% and 24.4% in a study 
done in the same areas of Ukerewe Islands among randomly 
selected adult community members as were observed by 
Kardoff et al. [8] and Kaatano et al. [15], respectively. The mor-
bidity related to S. mansoni was also much higher in the villag-
es on proximity with the lake shore, agreeing to a similar ob-
servation by Kaatano and others in 1993 (unpublished obser-
vations) in Ukerewe (PPF 30.7% in onshore vs 18.7% in in-
land villages) as was expected. S. mansoni normally is highly 
prevalent along the lake shore [16]. Since living on or near the 
lakeshore is ecological proxy for risky water-contact behavior 
because those individuals in these areas are more likely to un-
dertake risky water-contact behavior in comparison with the 
ones who are distant from the lake.
However, on the other hand, the prevalence of PPF of 
42.2% as observed in our study area was comparatively higher 
than other studies in the rest other East Africa along Lake Vic-
toria shore using the Niamey protocol. King et al. [17] in Ke-
nya revealed a prevalence of PPF of 3% while Booth et al. [18] 
recorded the prevalence of PPF of 31.5% and 6.1% in 2 villag-
es of Uganda along the shores of Lake Albert. Geographical 
variation in levels of morbidity and infection rate is a com-
mon phenomenon, in part mainly being attributed in part to 
the focal nature of transmission [19], which has been observed 
in even very close in adjacent communities [20]. 
The finding of the prevalence of PPF being significantly 
higher in male than female is as expected as and was also con-
firmed by other workers [8,9]. Water contact activities such as 
swimming and fishing which are normally commoner for 
males than females; in most cases of the male water contact 
(swimming, fishing, etc) takes long and usually involves most 
part of the body in contact with lake water. However, one of 
the important and striking observations in this study was the 
occurrence of the high prevalence of PPF (37%) in the teenage 
group of 10-20 years. Similar trends of observation were re-
corded by Malenganisho et al. [9] in Musozi village, Ukerewe 
Islands District and by Gabone et al. [21] in Kome Island, Sen-
gerema District, Lake Victoria. This result contrasts with that of 
Vennervald et al. [3] from an endemic area of Kenya where a 
similar age group did not show significant PPF despite high 
rates of splenomegaly and hepatomegaly. In another study in 
Ukerewe [15] which were rather more representative of all 
community members, its prevalence in same age group was 
12.5% while 5.4% of PPF was detected by El-Scheich et al. [22] 
among school age children in Ukerewe. This finding probably 
supports the ideas that intensive exposure to heavy infection 
during early childhood in high transmission areas is responsi-
ble for such rapid progression of morbidity. Earlier studies [23] 
estimated the time lapse between infection with S. mansoni 
and evolution of PPF in humans to be at least 5 years. Howev-
er, the evolution of PPF in our setting of Lake Victoria region 
as compared with Sudan [23] and other part of northern Afri-
ca might be longer where Kardoff et al. [8] classified it as inter-
mediate. Although our study did not include children less 
than 14 years, it can be inferred that in an established stable 
transmission area, such as the shores of Lake Victoria, PPF 
starts to develop in childhood. Such assumption is also sup-
ported by PPF (4.7%) detected in Ukerewe [15] among 5-10 
years age group.
Observation of the lower egg excretion detection rate (i.e., 
low S. mansoni infection prevalence) might be attributed to 
methodology of collection of stool samples. Due to logistic 
reason, in our case only 1 stool sample was collected instead 
of 2 samples in 2 consecutive days that might underestimate 
the infection rate due to the fact that by examination of a sin-
gle stool sample, particularly in low intensity, cases are fre-
quently missed as a result of less sensitive when only 1 stool 
sample is examined [24]. However, the procedures of sample 
collection and parasitological testing were ensured to be the 
same throughout the baseline survey. This fact is also support-
ed by relatively higher rate of periportal fibrosis and also by 
degree of discordance between hepatic fibrosis and demon-
stration of eggs in stools noted in our study; 65.1% (99/152) 
of those individuals with detectable hepatic fibrosis at the 
baseline survey had no demonstrable eggs in their stools.
Conclusively, a high S. mansoni-related morbidity justifies 
the implementation of mass drug administration and other 
intervention such as provision of alternative sources of water 
550  Korean J Parasitol Vol. 53, No. 5: 545-551, October 2015
supply (pumped wells) that has already started in the study 
area.
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